Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Sep 18, 2020
If You’re Making Investment Decisions Based on the Election, Don’t…

If You’re Making Investment Decisions Based on the Election, Don’t…

There is a long-held belief by investors that the President of the United States’ political party has a big impact on the stock market. The belief is that Democrats are bad for the market and that Republicans are good for the market. The truth is, since World War II, the market has performed better under Democrats than Republicans. But that doesn’t mean there is a cause and effect relationship there.

An article from Forbes back in July evaluated each president back to Harry Truman and the top two performances came under Democratic administrations. Bill Clinton saw the S&P gain 210% while he was in office and Barack Obama saw the index move up 182% while he was in office. Conversely, the two worst results were both under Republican administrations. George W. Bush saw the S&P drop 40% in his eight-year term and the index fell 20% during the five-year term of Richard Nixon.

Before anyone starts to think that they should vote for Joe Biden in November simply because the returns we saw under Presidents Clinton and Obama, let’s take a look at the circumstances behind the gains.

President Clinton was fortunate to be in office during an incredible expansion in technology. I was thinking about how much things changed in the early 90’s, as far as my own work environments. In 1990 I was working at a brokerage firm where I shared a Quotron with the guy in the cubicle next to me. Our “computer” sat on a Lazy Susan of sorts and we could swivel it back and forth as needed. Keep in mind the only thing a Quotron did was get you stock prices and some financial news.

By 1994 I was working for a regional bank in customer service area and every single workstation had its own computer. With these computers we could do almost everything for a customer—make a payment, transfer money, look up all of their transactions, etc. Within a few years I was working as a branch manager and all of our computers had internet capabilities.

The stock market benefitted greatly from the tech boom that happened in the early 90’s and the internet industry was still in its infancy. By the mid-90’s, the internet boom was really starting to hit its stride and then in the late 90’s everyone was replacing their hardware and software because of the Y2K concerns, creating yet another boost in tech sales to drive the market higher.

All of this took place while Bill Clinton was in office—the initial tech spending boom, the internet industry becoming mainstream, and the tech replacement cycle that occurred because of the new millennium. Did any of that have to do with the fact that that Clinton was a Democrat? Of course it didn’t. He was in the right place at the right time.

The Slowdown After the Boom

Flash forward to 2001 when President Bush took office and now we are seeing a big slowdown in tech spending. Well of course we are because everyone upgraded their hardware and software in 1999. Even before the election in November 2000 we were starting to see cracks in the bull market that we had been in for years. From August 2000 through October 2002, the S&P would lose 45% of its value.

President Bush had gotten a tax cut pushed through Congress and he had helped bring the country together after the 9/11 attacks. Despite his best efforts, the market still took a nosedive. Did that have anything to do with him being a Republican? Of course it didn’t. As fortunate as Clinton was to be the president when he was, Bush was just as unfortunate to president at a time when the economic cycle was bound to see a contraction.

The market started rebounding in 2003 and it did pretty well until 2007 when the financial crisis started. The booming housing market that was generated with a growing population and low interest rates created the “housing bubble”. Did Bush’s fiscal policies help create the boom? To some degree they did, but that isn’t what created the financial crisis. The term “too big to fail” became all too familiar to the majority of people. Banks had ventured in to trading, insurance, investments, etc. This created institutions that held far too much importance in various aspects of the financial system.

There was a piece of legislation that passed in 1999, under the Clinton administration, that allowed the process of banks expanding their reach in the financial industry. The Gramm-Leach-Bliley Act went in to effect in November 1999 and it repealed the Glass-Steagall Act that had limited bank operations since 1933. This change in legislation was a huge contributing factor in why the financial crisis was so bad and why the market dropped so greatly. Was this President Bush’s fault? Not really, and it also didn’t have anything to do with him being a Republican.

So now we have been through two bear markets in less than eight years and George W. Bush has been president during both. At the end of the financial crisis, we have seen legislation passed to bail out banks and auto manufacturers. We have also seen the Federal Reserve step in to cut interest rates to zero in late 2008. The target rate stayed at zero until late 2015. The bailouts and the low interest rates provided the necessary fuel to start the next big rally in the market.

The Next Phase in the Economic Cycle

Barack Obama took office in January 2009 after all of these moves had been made by Congress and the Fed. He was the beneficiary of being president while the Fed was incredibly accommodative. Did the huge rally during his eight-year term have anything to do with his fiscal policy? Maybe a little, but more credit probably belongs to the Fed’s monetary policies and the economic cycle.

The rally that started in the spring of 2009 continued through until it hit a rough patch at the end of 2015. The S&P moved sideways for a bit and then took off again in a trajectory that held until late 2018.

At this point we had transitioned to Donald Trump being president in January 2017. The market rally hardly changed its trajectory at all until the fourth quarter of 2018 and then it rallied right back until the COVID-19 pandemic hit this past spring. Did the rally from 2009 through 2018 have anything to do with Barack Obama’s fiscal policies? Maybe a little, but again the economic cycle and the Fed had a greater influence on the market.

The fact that the market hardly flinched when President Trump took over had little to do with him being a Republican. Sure he got the Tax Cuts and Jobs Act pushed through in late 2017, but that didn’t really change the trajectory of the S&P rally. It went in to effect in 2018. The act may have helped extend the rally, but it didn’t insulate the U.S. from a market correction in Q4 2018 and it didn’t help us when the global economy shutdown in Q2 2020.

When the market dropped so sharply in February and March ’20, it was a panic. It had everything to do with the uncertainty surrounding the COVID-19 virus and little to do with having a Republican president. The fact that the market rallied right back to new highs had more to do with the Fed once again cutting interest rates and Congress passing the first relief package. President Trump did help Democrats and Republicans shape the bill, so he does get credit for that.

Watch the Economic Cycle and Fed Policy

Personally, I am pretty neutral when it comes to politics. And as an investment analyst, I don’t really care whether the president is a Democrat or a Republican. I sure won’t be making my investment decisions based on which candidate has the lead heading in to the election in November. I am more concerned about where we are in the economic cycle and what the Fed’s policies are for the foreseeable future.

As we head in to the election, I think the winner is going to have a difficult time as we continue to deal with the pandemic and we haven’t had much of an economic downturn since the financial crisis. Sure we technically entered a recession in the second quarter as GDP shrank, but that was almost a self-induced recession as we shut the economy down in order to deal with the health crisis. That is not part of the normal economic cycle. It also doesn’t look like it is going to last very long, at least not in the eyes of many analysts and investors.

The Fed doesn’t seem to be much of a worry as they just announced earlier this week that they planned to keep interest rates low until at least 2023. They could still take additional measures to change monetary policy if needed, but the overall outlook for the Fed seems to be pretty accommodative.

My advice to investors is to make their investment decisions based on statistics and other analysis techniques and don’t worry about the election outcome. Keep an eye on the economic indicators and the Fed. These will help you prepare for the next recession and the next bear market.

Related Ticker: SPXC

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


SPXC sees its Stochastic Oscillator recovers from oversold territory

On July 31, 2026, the Stochastic Oscillator for SPXC moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 59 instances where the indicator left the oversold zone. In of the 59 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SPXC's RSI Indicator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SPXC just turned positive on August 04, 2026. Looking at past instances where SPXC's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SPXC advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

SPXC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SPXC as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SPXC moved below its 50-day moving average on July 07, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SPXC crossed bearishly below the 50-day moving average on July 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPXC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SPXC entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SPXC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.529) is normal, around the industry mean (5.439). P/E Ratio (37.320) is within average values for comparable stocks, (37.298). Projected Growth (PEG Ratio) (1.436) is also within normal values, averaging (1.611). SPXC's Dividend Yield (0.000) is considerably lower than the industry average of (0.013). SPXC's P/S Ratio (4.305) is slightly higher than the industry average of (2.223).

Notable companies

The most notable companies in this group are Johnson Controls International plc (NYSE:JCI), Owens Corning (NYSE:OC), Alpha Pro Tech Ltd (ASE:APT).

Industry description

The industry manufactures products used in the construction of residential and commercial buildings. The process involves using materials and other products, and processing them to create finished items such as doors, windows, light fittings, floor coverings, climate control products and other building components and home improvement products. Masco Corporation, Allegion PLC and Lennox International Inc. are major manufacturers of such products.

Market Cap

The average market capitalization across the Building Products Industry is 10.96B. The market cap for tickers in the group ranges from 14.02K to 104.95B. TT holds the highest valuation in this group at 104.95B. The lowest valued company is MTWD at 14.02K.

High and low price notable news

The average weekly price growth across all stocks in the Building Products Industry was -0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -2%. JLHL experienced the highest price growth at 34%, while AEHL experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Building Products Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was -3% and the average quarterly volume growth was -11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 51
Price Growth Rating: 53
SMR Rating: 70
Profit Risk Rating: 73
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
SPXC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an industrial conglomerate which manufactures and distributes industrial components

Industry BuildingProducts

Profile
Details
Industry
Industrial Conglomerates
Address
6325 Ardrey Kell Road
Phone
+1 980 474-3700
Employees
4100
Web
https://www.spx.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.